General Partner, Hatteras Venture Partners and Chairman, Viamet Pharmaceuticals
Former Executive Vice President, Finance and Business Development and Chief Financial Officer, Allergan, Inc.
Andrew von Eschenbach, M.D.
Former Commissioner, U.S. Food and Drug Administration
Adrian Howd, Ph.D.
Chief Investment Officer, Malin Corporation plc.
Former Vice Chairman, Investment Banking, Merrill Lynch & Co.
Douglas Reed, M.D.
General Partner, Hatteras Venture Partners
Robert Schotzinger, M.D., Ph.D.
President & Chief Executive Officer, Viamet Pharmaceuticals
S. Edward Torres
Managing Director, Lilly Ventures
Venture Partner, Intersouth Partners
Managing Director, Novartis Venture Fund
Chief Investment Officer, Lurie Holdings